ClinicalTrialStartPulse / compare
GlaxoSmithKline vs Nanjing First Hospital, Nanjing Medical University: ClinicalTrialStartPulse comparison
Nanjing First Hospital, Nanjing Medical University's enrollment of 612 is 1.0x GlaxoSmithKline's 610 (91st percentile). GlaxoSmithKline is dated 2026-11-03; Nanjing First Hospital, Nanjing Medical University 2026-10-29.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does GlaxoSmithKline compare to Nanjing First Hospital, Nanjing Medical University?
| Field | GlaxoSmithKline | Nanjing First Hospital, Nanjing Medical University |
|---|---|---|
| Sponsor | GlaxoSmithKline | Nanjing First Hospital, Nanjing Medical University |
| Sponsor type | Industry (pharma, biotech, medtech) | Academic and hospital |
| Study | A Study to Investigate Mocertatug Rezetecan as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02) | Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication. |
| NCT ID | NCT07684599 | NCT07904429 |
| Phase | Phase 3 | Phase 3 |
| Status | recruiting | recruiting |
| Conditions | Neoplasms, Endometrial | Helicobacter Infection |
| Intervention types | drug | drug |
| Target enrollment | 610 | 612 |
| Site countries | Canada, Japan, South Korea | China |
| Posted | 2026-07-06 | 2026-10-29 |
| Planned start | 2026-09-24 | 2026-07-15 |
| Event | Started recruiting | Newly registered study |
| Event date | 2026-09-24 | 2026-10-29 |
| Last update posted | 2026-11-03 | |
| enrollment percentile | 91st | 91st |
| Score | 100/100 | 70/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: GlaxoSmithKline · Nanjing First Hospital, Nanjing Medical University
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.